Diabetes mellitus as a risk factor for tuberculosis in the Federal District between 2019 and September 2023
DOI:
https://doi.org/10.51723/hrj.v7i34.1164Keywords:
Tuberculosis, Diabetes, Risk factors, ComorbiditiesAbstract
Objective: ro identify the association between tuberculosis and diabetes mellitus, observing the clinical and epidemiological behavior of this binomial, in the Federal District (DF), from 2019 to September 2023. Methodology: epidemiological cross-sectional and analytical study, with secondary data extracted from the Notifiable Diseases Information System (SINAN) via DATASUS, of patients with tuberculosis and diabetes mellitus in the DF. All reported cases of tuberculosis with record of diabetes mellitus in the DF were included, excluding incomplete or duplicated records. Dependent variable: clinical outcomes of tuberculosis (cure, relapse, drug resistant tuberculosis, treatment default and death); independent variables: diabetes mellitus (yes/no); sociodemographic covariates: sex, age, race and education level, and homelessness; clinical and lifestyle covariates: pulmonary/extrapulmonary form, positive sputum smear microscopy, HIV, mental illness, smoking, alcoholism, illicit drugs use, and health professionals. Relative and absolute frequencies, chisquare and Fisher’s Exact tests were used, adopting statistical significance of p<0.05, using BioEstat 5.0 software. Results: a total of 1,574 patients were evaluated. The predominant epidemiological profile was male individuals, over 65 years old, mixed-race (pardo), with low education, smokers, without HIV coinfection. Diabetic tuberculosis patients progress less to cure, with more deaths and cases of drug-resistant tuberculosis. Conclusion: the incidence of the tuberculosis-diabetes mellitus binomial shows a progressive increase in cases over the years, with worse clinical outcomes. The integrated management of these two associated diseases is essential to reduce complications and prevent deaths.
References
Ministério da Saúde. Manual de recomendações e controle da tuberculose no Brasil [Internet]. 2ª ed. Brasília, DF: MS; 2019 [atualizado em 29 maio 2024]. Disponível em: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/svsa/tuberculose/manualderecomendacoes-e-controle-da-tuberculose-no-brasil-2a-ed.pdf/view
Loscalzo J, Fauci AS, Kasper DL, et al. Medicina interna de Harrison. 21. ed. São Paulo: Grupo A; 2024.
Ministério da Saúde. Informativo sobre o teste rápido molecular para tuberculose (TRM-TB) [Internet]. Brasília, DF: MS; 2024. Disponível em: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/svsa/tuberculose/teste-rapidomolecular-para-tuberculose-trm-tb/view
Ministério da Saúde. Protocolo de vigilância da infecção latente pelo Mycobacterium tuberculosis no Brasil [Internet]. 2. ed. Brasília, DF: MS; 2022. Disponível em: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/svsa/tuberculose/protocolo-devigilancia-da-infeccao-latente-pelo-mycobacterium-tuberculosis-no-brasil.pdf/view
World Health Organization. Consolidated guidelines on tuberculosis:module 4 – treatment [Internet]. Geneva: WHO; 2020. Disponível em: https://www.who.int/health-topics/tuberculosis#tab=tab_1
Pereira SM, Araújo GS, Santos CAST, Oliveira MG, Barreto ML. Associação entre diabetes e tuberculose: estudo de caso-controle [Internet]. Rev Saude Publica. 2016;50:82. Disponível em: https://www.scielo.br/j/rsp/a/BbqG3WLBskYCTns4xD93vrN/?format=pdf&lang=pt
Sociedade Brasileira de Diabetes. Brasil já tem cerca de 20 milhões de pessoas com diabetes [Internet]. 2025 Jan 31. Disponível em: https://diabetes.org.br/brasil-ja-tem-cerca-de-20-milhoes-de-pessoas-com-diabetes/
Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis. 2009;9(12):737-46. Disponível em: https://pubmed.ncbi.nlm.nih.gov/19926034/
Lopez LN, Martinez AG, Garcia Hernandez MH, Hernandez Pando R, Castañeda Delgado JE, et al. Type 2 diabetes alters the basal phenotype of human macrophages and diminishes their capacity to respond, internalise and control Mycobacterium tuberculosis. Mem Inst Oswaldo Cruz. 2018;113(4):e170326. Disponível em: https://www.scielo.br/j/mioc/a/gpM47MdNsZxmhLZzKWbcf8d/?lang=en
Jørgensen ME, Faurholt-Jepsen D. Is there an effect of glucose lowering treatment on incidence and prognosis of tuberculosis? A systematic review. Curr Diab Rep. 2014 [acesso em 2023 Dez 23];14(7):505. Disponível em: https://pubmed.ncbi.nlm.nih.gov/24806518/
World Health Organization. TB and diabetes [Internet]. Geneva, CH: WHO; 2025 [acesso em 2025 Fev 04]. Disponível em: https://www.who.int/publications/digital/global-tuberculosis-report-2021/featured-topics/tb-diabetes
Berra TZ, Ramos ACV, Alves YM, Tavares RBV, Tartaro AF, Nascimento MCD, et al. Impact of COVID-19 on tuberculosis indicators in Brazil: a time series and spatial analysis study. Trop Med Infect Dis. 2022 Sep [acesso em 2023 Dez 20];7(9):247. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC9500936/
Rawat J, Sindhwani G, Biswas D. Effect of age on presentation with diabetes: comparison of nondiabetic patients with new smear-positive pulmonary tuberculosis patients. Lung. 2011;28(3):187-90. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3162756/
Restrepo BI. Diabetes and tuberculosis. Microbiol Spectr. 2016;4(6):10.1128. Available from: https://pubmed.ncbi.nlm.nih.gov/28084206/
Paz LC, Saavedra CAPB, Braga JU, Kimura H, Evangelista MSN. Análise da sazonalidade da tuberculose nas capitais brasileiras e Distrito Federal, Brasil, no período de 2001 a 2019. Cad Saude Publica. 2022;38(7):e00291321. Disponível em: https://www.scielo.br/j/csp/a/C3SM7h8ngf4b569D8FrnB6r/
Reis-Santos B, Locatelli R, Horta BL, Faerstein E, Sanchez MN, Riley LW, et al. Socio demographic and clinical differences in subjects with tuberculosis with and without diabetes mellitus in Brazil: a multivariate analysis. PLoS One. 2013;8(4):e62604. Available from: https://doi.org/10.1371/journal.pone.0062604
Santana LG, Almeida JL, Oliveira CAM, Hickson LS, Daltro C, et al. Diabetes está associado com pior apresentação clínica em pacientes com tuberculose no Brasil: um estudo de coorte retrospectivo. PLoS One. 2016;11(1):e0146876. Disponível em: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0146876&type=printable
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Laysa Priscilla Carvalho Cabral, Marcus Vinícius Jacome Noronha, Viviane Cristina Uliana Peterle, Jorge Vinícius Sanches Carlos Rodrigues, Matheus de Carvalho Naves

This work is licensed under a Creative Commons Attribution 4.0 International License.
Esta licença permite que outros distribuam, remixem, adaptem e desenvolvam seu trabalho, mesmo comercialmente, desde que atribuam crédito à revista pela criação original.









